Daxor Corporation (DXR)

USD 7.34

(-1.08%)

Long Term Debt Summary of Daxor Corporation

  • Daxor Corporation's latest annual long term debt in 2023 was 755.65 Thousand USD , down -38.52% from previous year.
  • Daxor Corporation's latest quarterly long term debt in 2024 Q2 was 1.64 Million USD , down 0.0% from previous quarter.
  • Daxor Corporation reported annual long term debt of 1.22 Million USD in 2022, down -59.33% from previous year.
  • Daxor Corporation reported annual long term debt of 3.02 Million USD in 2021, up 1670.79% from previous year.
  • Daxor Corporation reported quarterly long term debt of 1.64 Million USD for 2024 Q1, up 118.31% from previous quarter.
  • Daxor Corporation reported quarterly long term debt of 755.65 Thousand USD for 2023 Q3, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Daxor Corporation (2023 - 1989)

Historical Annual Long Term Debt of Daxor Corporation (2023 - 1989)

Year Long Term Debt Long Term Debt Growth
2023 755.65 Thousand USD -38.52%
2022 1.22 Million USD -59.33%
2021 3.02 Million USD 1670.79%
2020 170.68 Thousand USD -87.29%
2019 1.34 Million USD -69.86%
2018 4.45 Million USD 2.77%
2017 4.33 Million USD 54.71%
2016 2.8 Million USD -27.14%
2015 3.84 Million USD -82.0%
2014 21.35 Million USD 5.49%
2013 20.24 Million USD 89.6%
2012 10.67 Million USD -24.02%
2011 14.05 Million USD -48.69%
2010 27.39 Million USD 145.41%
2009 11.16 Million USD -17.22%
2008 13.48 Million USD 256.48%
2007 3.78 Million USD 8.59%
2006 3.48 Million USD -50.83%
2005 7.08 Million USD 72.21%
2004 4.11 Million USD 64.39%
2003 2.5 Million USD 74.48%
2002 1.43 Million USD 43.4%
2001 1 Million USD -43.67%
2000 1.77 Million USD -27.35%
1999 2.44 Million USD 16.37%
1998 2.1 Million USD -16.0%
1997 2.5 Million USD 56.25%
1996 1.6 Million USD 0.0%
1995 1.6 Million USD -58.97%
1994 3.9 Million USD -13.33%
1993 4.5 Million USD -53.61%
1992 9.7 Million USD 6.59%
1991 9.1 Million USD 62.5%
1990 5.6 Million USD -28.21%
1989 7.8 Million USD -30.97%

Peer Long Term Debt Comparison of Daxor Corporation

Name Long Term Debt Long Term Debt Difference
Akoya Biosciences, Inc. 75.25 Million USD 98.996%
AngioDynamics, Inc. 3.93 Million USD 80.816%
AtriCure, Inc. 60.59 Million USD 98.753%
Avinger, Inc. - USD -Infinity%
Azenta, Inc. 60.43 Million USD 98.75%
BioLife Solutions, Inc. 18.31 Million USD 95.873%
The Cooper Companies, Inc. 2.52 Billion USD 99.97%
Ekso Bionics Holdings, Inc. 4.83 Million USD 84.361%
Femasys Inc. 4.25 Million USD 82.254%
GlucoTrack, Inc. 196 Thousand USD -285.54%
Harvard Bioscience, Inc. 30.7 Million USD 97.539%
Hologic, Inc. 2.49 Billion USD 99.97%
ICU Medical, Inc. 1.57 Billion USD 99.952%
Intuitive Surgical, Inc. -82.1 Million USD 100.92%
KORU Medical Systems, Inc. 3.65 Million USD 79.314%
LeMaitre Vascular, Inc. 16.62 Million USD 95.454%
Innovative Eyewear, Inc. - USD -Infinity%
Innovative Eyewear, Inc. - USD -Infinity%
Masimo Corporation 871.7 Million USD 99.913%
Microbot Medical Inc. 40 Thousand USD -1789.148%
Meihua International Medical Technologies Co., Ltd. 4592.00 USD -16355.989%
Merit Medical Systems, Inc. 823.01 Million USD 99.908%
Nephros, Inc. 1.39 Million USD 45.636%
NovoCure Limited 596.24 Million USD 99.873%
NEXGEL, Inc. 513 Thousand USD -47.302%
NEXGEL, Inc. 513 Thousand USD -47.302%
Singular Genomics Systems, Inc. 67.52 Million USD 98.881%
OraSure Technologies, Inc. 11.38 Million USD 93.364%
Pro-Dex, Inc. 7.53 Million USD 89.973%
Pulse Biosciences, Inc. 8.08 Million USD 90.655%
Predictive Oncology Inc. 2.18 Million USD 65.479%
Precision Optics Corporation, Inc. 1.93 Million USD 61.008%
QuidelOrtho Corporation 2.27 Billion USD 99.967%
Repligen Corporation 510.14 Million USD 99.852%
Sanara MedTech Inc. 9.11 Million USD 91.708%
STAAR Surgical Company 31.46 Million USD 97.599%
Sharps Technology, Inc. - USD -Infinity%
Utah Medical Products, Inc. 295 Thousand USD -156.156%
DENTSPLY SIRONA Inc. 1.79 Billion USD 99.958%
Jin Medical International Ltd. - USD -Infinity%